Natera to Participate in Upcoming Investor Conferences

Rhea-AI Summary

Natera, Inc. (NASDAQ: NTRA), a leader in cell-free DNA testing, announced participation in two significant conferences. Alexey Aleshin, MD, will join a panel at the BTIG Virtual MedTech Conference on February 18, 2021, at 10:00 a.m. PT. Additionally, Steve Chapman, CEO, and Mike Brophy, CFO, will engage in a fireside chat at the 10th Annual SVB Leerink Global Healthcare Conference on February 26, 2021, at 11:20 a.m. PT. Live webcasts will be available at investor.natera.com.

SAN CARLOS, Calif., Feb. 11, 2021 /PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA), a pioneer and global leader in cell-free DNA testing, today announced that Alexey Aleshin, MD, Natera's Senior Medical Director of Oncology, will participate in a panel discussion at the BTIG Virtual MedTech, Digital Health, Life Science and Diagnostic Tools Conference. Additionally, Steve Chapman, CEO, and Mike Brophy, CFO, will participate in a fireside chat at the 10^th Annual SVB Leerink Global Healthcare Conference.

Details are as follows:

BTIG Virtual MedTech, Digital Health, Life Science and Diagnostic Tools Conference
Date:	Thursday, February 18, 2021
Time:	10:00 a.m. PT (1:00 p.m. ET)
10th Annual SVB Leerink Global Healthcare Conference
Date:	Friday, February 26, 2021
Time:	11:20 a.m. PT (2:20 p.m. ET)

Access to the live webcasts will be available at investor.natera.com.

About Natera

Natera is a pioneer and global leader in cell-free DNA testing from a simple blood draw. The mission of the company is to change the management of disease worldwide with a focus on women's health, oncology, and organ health. Natera operates ISO 13485-certified and CAP-accredited laboratories certified under the Clinical Laboratory Improvement Amendments (CLIA) in San Carlos, California and Austin, Texas. It offers proprietary genetic testing services to inform obstetricians, transplant physicians, oncologists, and cancer researchers, including biopharmaceutical companies, and genetic laboratories through its cloud-based software platform. For more information, visit natera.com. Follow Natera on LinkedIn.

Contacts

Investor Relations: Mike Brophy, CFO, Natera, Inc., 510-826-2350
Media: Paul Greenland, VP of Corporate Marketing, Natera, Inc., pr@natera.com 

 

 

View original content to download multimedia:http://www.prnewswire.com/news-releases/natera-to-participate-in-upcoming-investor-conferences-301226652.html

SOURCE Natera, Inc.

FAQ

What events will Natera (NTRA) participate in during February 2021?

Natera (NTRA) will participate in the BTIG Virtual MedTech Conference on February 18, 2021, and the 10th Annual SVB Leerink Global Healthcare Conference on February 26, 2021.

Who is speaking at the BTIG Virtual MedTech Conference for Natera?

Alexey Aleshin, MD, Natera's Senior Medical Director of Oncology, will participate in the BTIG Virtual MedTech Conference.

When is Natera's fireside chat at the SVB Leerink Global Healthcare Conference?

Natera's fireside chat at the SVB Leerink Global Healthcare Conference is scheduled for February 26, 2021, at 11:20 a.m. PT.

Where can I watch the live webcasts for Natera's conference participation?

Live webcasts of Natera's participation in the conferences can be accessed at investor.natera.com.

What is Natera's focus in the healthcare market?

Natera focuses on cell-free DNA testing, aiming to change disease management with a focus on women's health, oncology, and organ health.